Prot # EXC 001-201: A Phase 2, Randomized, Double-Blind, Within-Subject Controlled, Dose Ranging Study to Evaluate Efficacy and Safety of EXC 001 for the Treatment of Incision Scars in the Pannus of Subjects Undergoing an Elective Abdominoplasty